Status:

NOT_YET_RECRUITING

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

Lead Sponsor:

Medtronic Neurovascular Clinical Affairs

Conditions:

Intracranial Aneurysm

Eligibility:

All Genders

22+ years

Brief Summary

The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing ...

Detailed Description

The INSPIRE Pipeline™ Vantage Post Approval Study is a, prospective, multi-center, single-arm clinical study to collect safety and effectiveness data in patients undergoing treatment for intracranial ...

Eligibility Criteria

Inclusion

  • Patient or legally authorized representative (LAR) has provided written informed consent using the Ethics Board and Medtronic approved Informed Consent Form and agrees to comply with the protocol requirements. HIPAA/data protection authorization has been provided and signed by the patient (or patient's LAR) as applicable per local law.
  • Patient has an intracranial aneurysm intended to be treated with the Pipeline™ Vantage Embolization Device with Shield Technology™.
  • Patient is an adult per local law at time of consent.

Exclusion

  • Patient with any contraindications for the device or procedure per the Pipeline™ Vantage Device local geography IFU.
  • Patient who may be unable to complete the study follow-up.
  • The Investigator determined that the health of the patient may be compromised by the patient's enrollment.
  • Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
  • Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results.

Key Trial Info

Start Date :

December 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2033

Estimated Enrollment :

118 Patients enrolled

Trial Details

Trial ID

NCT06604884

Start Date

December 1 2025

End Date

September 1 2033

Last Update

December 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

McLaren Healthcare

Flint, Michigan, United States, 48532